IGHG3 and COVID-19: Recent studies have shown that COVID-19 patients and those receiving vaccination with mRNA-based COVID-19 vaccines develop a robust IgG response in healthy adults, consisting mainly of IgG1 and IgG3 subclasses, with neutralizing activity against SARS-CoV-2 [6,7].